Can we count your visit with Google Analytics? No ads, no profiles. Details
RXRX
NASDAQAnalystsBuy6+108%Health Care · Biotechnology
Each weekday: the watchlist of pullbacks inside uptrends, every new ticker teardown, and the bubble shifts that move names like this one. Free. Education, not advice.
Free when you join: the $HOOD Teardown Dossier (Robinhood Markets), the full desk file we sell in the shop. One per new reader.
No spam. One email per day max, unsubscribe in one click. Pro ($49/mo) includes every dossier and report in the shop.
AI-driven drug discovery platform - phenomics imaging + foundation models trained on internal cellular data. NVIDIA collaboration ($50M strategic investment 2023) anchors the BioHive-2 supercomputer for in-silico pipeline scaling. Q1 2026 reported $665.2M cash and $81.1M operating burn; revenue $6.5M missed $16.1M consensus by ~60%, driving renewed dilution-risk concern despite stronger pipeline + lower R&D YoY.
It reads our $RXRX data (thesis, key levels, peers, a year of prices) and any chart screenshot you paste, then explains the setup in plain English. Free with an email login, 5 questions a day. Education only: it never tells you to buy or sell, and it can be wrong, so check the numbers.
High-signal only
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.